PortfoliosLab logoPortfoliosLab logo
GN0M.DE vs. ZPDH.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GN0M.DE vs. ZPDH.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and SPDR S&P US Health Care Select Sector UCITS ETF (ZPDH.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than ZPDH.DE's -1.12% return.


GN0M.DE

1D
5.61%
1M
11.50%
YTD
12.99%
6M
9.82%
1Y
55.73%
3Y*
-1.90%
5Y*
10Y*

ZPDH.DE

1D
2.83%
1M
5.47%
YTD
-1.12%
6M
-0.34%
1Y
13.29%
3Y*
3.67%
5Y*
6.73%
10Y*
8.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GN0M.DE vs. ZPDH.DE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
12.99%5.67%-12.40%-9.04%-32.50%-7.90%
ZPDH.DE
SPDR S&P US Health Care Select Sector UCITS ETF
-1.12%1.73%8.46%-1.73%3.31%7.83%

Correlation

The correlation between GN0M.DE and ZPDH.DE is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.48

Correlation (3Y)
Calculated over the trailing 3-year period

0.42

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2021

0.43

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GN0M.DE vs. ZPDH.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GN0M.DE
GN0M.DE Risk / Return Rank: 5858
Overall Rank
GN0M.DE Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 6161
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 5454
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 6868
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 5050
Martin Ratio Rank

ZPDH.DE
ZPDH.DE Risk / Return Rank: 2525
Overall Rank
ZPDH.DE Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
ZPDH.DE Sortino Ratio Rank: 2727
Sortino Ratio Rank
ZPDH.DE Omega Ratio Rank: 2424
Omega Ratio Rank
ZPDH.DE Calmar Ratio Rank: 2626
Calmar Ratio Rank
ZPDH.DE Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GN0M.DE vs. ZPDH.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and SPDR S&P US Health Care Select Sector UCITS ETF (ZPDH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GN0M.DEZPDH.DEDifference
Sharpe ratioReturn per unit of total volatility

+1.12

Sortino ratioReturn per unit of downside risk

+1.41

Omega ratioGain probability vs. loss probability

1.33

1.16

+0.17

Calmar ratioReturn relative to maximum drawdown

3.32

1.21

+2.12

Martin ratioReturn relative to average drawdown

8.35

2.95

+5.41

GN0M.DE vs. ZPDH.DE - Sharpe Ratio Comparison

The current GN0M.DE Sharpe Ratio is 2.00, which is higher than the ZPDH.DE Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of GN0M.DE and ZPDH.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GN0M.DEZPDH.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.00

0.89

+1.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.56

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

0.46

-0.80

Drawdowns

GN0M.DE vs. ZPDH.DE - Drawdown Comparison

The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than ZPDH.DE's maximum drawdown of -26.61%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and ZPDH.DE.


Loading charts...

Drawdown Indicators


GN0M.DEZPDH.DEDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-26.61%

-40.58%

Max Drawdown (1Y)

Largest decline over 1 year

-16.68%

-10.77%

-5.91%

Max Drawdown (3Y)

Largest decline over 3 years

-48.19%

-22.64%

-25.55%

Max Drawdown (5Y)

Largest decline over 5 years

-22.64%

Max Drawdown (10Y)

Largest decline over 10 years

-26.61%

Current Drawdown

Current decline from peak

-41.03%

-7.28%

-33.75%

Average Drawdown

Average peak-to-trough decline

-43.13%

-5.80%

-37.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.65%

4.41%

+2.24%

Volatility

GN0M.DE vs. ZPDH.DE - Volatility Comparison

Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to SPDR S&P US Health Care Select Sector UCITS ETF (ZPDH.DE) at 5.13%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than ZPDH.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GN0M.DEZPDH.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.15%

5.13%

+3.02%

Volatility (6M)

Calculated over the trailing 6-month period

19.69%

10.16%

+9.53%

Volatility (1Y)

Calculated over the trailing 1-year period

27.68%

14.63%

+13.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.49%

14.47%

+17.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.49%

15.77%

+15.72%

GN0M.DE vs. ZPDH.DE - Expense Ratio Comparison

GN0M.DE has a 0.50% expense ratio, which is higher than ZPDH.DE's 0.15% expense ratio.


Dividends

GN0M.DE vs. ZPDH.DE - Dividend Comparison

Neither GN0M.DE nor ZPDH.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


GN0M.DE and ZPDH.DE have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, ZPDH.DE is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.

ZPDH.DE is cheaper with a 0.15% expense ratio, compared with 0.50% for GN0M.DE.

GN0M.DE tracks Solactive Genomics, while ZPDH.DE tracks S&P Health Care Select Sector. They also come from different issuers: Global X and State Street. Their fees differ too: 0.50% for GN0M.DE and 0.15% for ZPDH.DE.

Portfolio Optimizer

Find the right allocation for GN0M.DE and ZPDH.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer